A National Observation Study on Pelvic Floor Dysfunction Diseases in China
1 other identifier
observational
10,000
0 countries
N/A
Brief Summary
In this protocol, our team intend to conduct a nation-wide multicenter cohort research to screening for PFD symptoms in early postnatal women in China. Beside clinically significant symptoms, we will also measure the recovery trend of pelvic muscle function, aiming to determine the clinically significant alterations that are sensitive to predict the PFD risks. This is an observational prospective cohort study, following a natural regular clinical visit process. Patients will voluntarily decide whether to receive PFD related treatments and the types of treatments to adopt. Therefore, we will also be able to compare the effectiveness of treatments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
September 8, 2023
CompletedFirst Posted
Study publicly available on registry
September 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedSeptember 14, 2023
October 1, 2022
5 months
September 8, 2023
September 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Urinary incontinence
UI will be diagnosed via gynecological examination and self-reported symptoms
6 months
Secondary Outcomes (1)
Pelvic organ prolapse
6 months
Other Outcomes (1)
Pelvic muscle function
6 months
Interventions
biofeedback with Pelvic floor muscle training (PFMT)
Eligibility Criteria
All adult women in early postnatal period, 42 days+15 days after delivery, are eligible to participate.
You may qualify if:
- Postpartum women: 42 days+15 days after delivery
- Age:20-45
- Consent to participate in the research.
You may not qualify if:
- Refuse gynecological and/or obstetrical examinations.
- Diagnosed with psychiatric disorders
- Diagnosed with other severe illnesses
- Received pelvic floor treatments
- Other factors that may confound with the research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2023
First Posted
September 14, 2023
Study Start
September 1, 2023
Primary Completion
February 1, 2024
Study Completion
December 1, 2024
Last Updated
September 14, 2023
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share